SCHEMBL19601366

SCHEMBL19601366

CCC(Cc1ccc(C(C)C(=O)N2CC(C)N(C(=O)C(C)c3ccc(CC(CC)(C(=O)c4ccc(F)cc4)N(C)C)cc3)CC2C)cc1)(C(=O)c1ccc(F)cc1)N(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPK14 Q16539 3/20 0.33
VNN1 O95497 1/20 0.33
MAPK11 Q15759 2/20 0.32
MAPK13 O15264 1/20 0.32
MAPK12 P53778 1/20 0.32
NQO2 P16083 1/20 0.32
MAPKAPK2 P49137 1/20 0.32
ACTR2 P61160 1/20 0.32
CCR1 P32246 1/20 0.32
KCNH2 Q12809 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
DPP4 P27487 2/20 0.32
DPP7 Q9UHL4 2/20 0.32
RIPK1 Q13546 1/20 0.32
AGTR2 P50052 1/20 0.32
DPP8 Q6V1X1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19601244 0.89 MLNR (0.31) MLNRCYP3A4KCNH2
SCHEMBL19601232 0.86 MLNR (0.42) MLNRCYP3A4ALDH1A1LMNA
SCHEMBL19601247 0.85 MAPKAPK2 (0.35) ALDH1A1MAPKAPK2
SCHEMBL17269438 0.82 PTGS2 (0.42) ALDH1A1LMNARIPK1
SCHEMBL23152946 0.82 TSHR (0.52) MLNRCYP3A4ALDH1A1SMN1; SMN2DPP4
SCHEMBL17269443 0.82 MLNR (0.39) MLNRCYP3A4ALDH1A1LMNA
SCHEMBL20988127 0.80 MLNR (0.38) MLNRCYP3A4ALDH1A1LMNA
SCHEMBL2704437 0.80 RIPK1 (0.46) ALDH1A1LMNARIPK1
SCHEMBL19601240 0.77 MAPKAPK2 (0.31) MAPKAPK2
SCHEMBL19601161 0.76 POLB (0.48) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11079675-B2 Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink DIC CORPORATION (JP) 2021-08-03 US disclosed
US-20190137872-A1 NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PRINTING INK, AND PRINTED MATTER SURING THE PRINTING INK DIC CORPORATION (JP) 2019-05-09 US disclosed
WO-2017195428-A1 NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT THEREOF, PRINTING INK, AND PRINTED MATTER USING PRINTING INK DIC株式会社 2017-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11079675-B2 Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink EPB41, F12, CDK1 MLNR 3815/4885CYP3A4 1229/4885ALDH1A1 862/4885
US-20190137872-A1 NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PRINTING INK, AND PRINTED MATTER SURING THE PRINTING INK EPB41, CDK1, CDKN1A MLNR 4209/4885CYP3A4 1086/4885ALDH1A1 615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.